[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Myocarditis data from Korea", "description": "19.8% of total VRM was severe \n\nCOVID-19 vaccination-related myocarditis: a Korean nationwide study\n\nhttps://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehad339/7188747?utm_source=substack&amp;utm_medium=email\n\nNationwide study,\n\nincidence and outcomes of COVID-19 vaccination-related myocarditis (VRM).\n\n44, 276, 704 individuals, at least 1 dose\n\nIncidence and clinical courses of VRM cases\n\nDiagnosis confirmed by Expert Adjudication Committee of the Korea Disease Control and Prevention Agency\n\nCOVID-19 VRM\n\n1, 533 presumptive cases \n\nConfirmed in 480 cases\n\n(1.08 cases per 100 000 persons)\n\nIncidence was significantly higher in men\n\nMen, 1.35 per 100 000 persons\n\nWomen, 0.82 per 100 000 persons\n\nMales aged 12 to 17, 5.29 cases per 100 000 persons\n\nFemales over 70, 0.16 cases per 100 000 persons\n\nCDC today\nhttps://www.cdc.gov/vaccines/covid-19/clinical-considerations/interim-considerations-us.html\n\nCOVID-19 vaccination is recommended for everyone ages 6 months and older in the United States for the prevention of COVID-19.\n\nMostly after first or second dose\n\nmRNA vaccines compared to other vaccines\n\nVRM after mRNA vaccines, 1.46 per 100 000 persons\n\nVRM after AZ vaccine, 0.14 per 100 000 persons\n\nP les than 0.001\n\nDenmark, VRM\n\nhttps://pubmed.ncbi.nlm.nih.gov/34916207/\n\nBNT162b2, 1.4 per 100 000 vaccinated individuals\n\nmRNA-1273, 4.2 per 100 000\n\n(within 28 days of vaccination) \n\nSevere VRM was identified in 95 cases\n\n19.8% of total VRM \n\n(0.22 per 100 000 vaccinated persons)\n\n85 intensive care unit admission\n\n(17.7% of total VRM)\n\n36 cases of fulminant myocarditis\n\n7.5% of total VRM\n\n21 cases required extracorporeal membrane oxygenation\n\n(4.4% of total VRM)\n\n21 more severe adverse events \n\n(4.4% of total VRM)\n\nEight out of 21 were sudden cardiac dea*** (SCD)\n\n(attributable to VRM proved by an autopsy)\n\nAll cases of SCD attributable to VRM were aged under 45 years and received mRNA vaccines\n\n1 heart transplantation\n\nConclusion\n\nMoreover, SCD should be closely monitored as a potentially fat** complication of COVID-19 vaccination.\n\nMost common presenting symptom\n\nChest pain or discomfort\n\nMedian time from the vaccination to symptom onset, 3 days \n\n(IQR, 1\u201310 days) \n\nCOVID-19 VRM incidence was highest in mRNA-1273 vaccine (Moderna)\n\nFollowed by BNT162b2\n\nJ and J Ad26 0.20 per 100 000 persons\n\nAZ ChAdOx1 0.14 per 100 000 persons", "link": "https://www.youtube.com/watch?v=CROf3xmGzYI", "date_published": "2023-06-17 15:25:29+00:00", "persistent": false, "user": null, "language": "en-UK"}]